Jubilant Life Sciences has informed about a Press Release dated May 27, 2016 titled ‘Jubilant Biosys Enters into Exclusive out - Licensing Agreement with Checkpoint Therapeutics for Novel BET Inhibitors’.
The above information is a part of company’s filings submitted to BSE.